NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 60687-0304-21 — Captopril 12.5 mg oral tabletAI (347 hospitals, 26,787–27,291 samples)
• NDC 50268-0584-13 — Niacin extended-release 500 mg tabletsAI (144 hospitals, 26,787–27,291 samples)
• NDC 68462-0437-30 — Olmesartan 20 mg tablets, 30-count bottleAI (329 hospitals, 26,532–27,288 samples)
• NDC 00121-1190-30 — Sodium citrate and citric acid oral solutionAI (346 hospitals, 25,924–27,283 samples)
• NDC 00093-1712-01 — warfarin 1 mg tabletAI (431 hospitals, 26,713–27,280 samples)
• NDC 00009-0856-08 — Carboprost tromethamine injection 250 mcg/mLAI (686 hospitals, 26,098–27,277 samples)
• NDC 00023-3205-03 — Bimatoprost eye dropsAI (417 hospitals, 26,256–27,273 samples)
• NDC 00713-0683-31 — GENTAMICIN 0.1 % TOPICAL CREAMAI (99 hospitals, 26,351–27,269 samples)
• NDC 00168-0041-60 — BETAMETHASONE VALERATE 0.1 % LOTIONAI (178 hospitals, 26,325–27,261 samples)
• NDC 70954-0496-10 — Nitrofurantoin oral liquid, 25 mg per 5 mLAI (144 hospitals, 26,342–27,260 samples)
• NDC 00998-0203-15 — PILOCARPINE 1 % EYE DROPSAI (158 hospitals, 26,324–27,251 samples)
• NDC 00641-6056-10 — Midazolam injection, 10 mg per 10 mL vialAI (247 hospitals, 24,073–27,250 samples)
• NDC 70092-9338-07 — Vancomycin 500 mg in saline infusionAI (143 hospitals, 26,981–27,242 samples)
• NDC 00065-0397-02 — CYCLOPENTOLATE 2 % EYE DROPSAI (440 hospitals, 26,244–27,216 samples)
• NDC 00023-9177-05 — Brimonidine tartrate 0.15% eye drops, 5 mLAI (285 hospitals, 26,232–27,204 samples)
• NDC 68084-0708-25 — Extended-release bupropion 150 mg tabletsAI (438 hospitals, 26,521–27,178 samples)
• NDC 75907-0069-01 — Nortriptyline 10 mg oral capsulesAI (472 hospitals, 26,539–27,169 samples)
• NDC 00093-4177-74 — Cephalexin 250 mg/5 mL oral liquidAI (274 hospitals, 26,381–27,164 samples)
• NDC 00065-0359-02 — Cyclomydril eye drops for pupil dilationAI (717 hospitals, 26,019–27,162 samples)
• NDC 69315-0134-01 — Imipramine 25 mg tabletsAI (544 hospitals, 26,564–27,158 samples)
• NDC 66993-0490-36 — Ibuprofen lysine injection, 20 mg per 2 mL vialAI (324 hospitals, 26,303–27,158 samples)
• NDC 50268-0260-13 — Divalproex sodium 500 mg extended-release tabletAI (305 hospitals, 26,635–27,157 samples)
• NDC 70436-0207-80 — Sodium nitroprusside IV solutionAI (71 hospitals, 26,252–27,152 samples)
• NDC 00904-6505-61 — Memantine 5 mg tabletsAI (501 hospitals, 26,518–27,148 samples)
• NDC 00409-4887-23 — Sterile water for injectionAI (377 hospitals, 26,806–27,148 samples)
• NDC 00536-1294-34 — DICLOFENAC 1 % TOPICAL GELAI (192 hospitals, 26,283–27,147 samples)
• NDC 00904-7093-61 — Oxycodone and acetaminophen tablets 5 mg/325 mgAI (289 hospitals, 26,479–27,145 samples)
• NDC 00245-0860-70 — Metronidazole 0.75% vaginal gelAI (422 hospitals, 26,240–27,140 samples)
• NDC 50268-0350-15 — Gemfibrozil 600 mg tabletsAI (387 hospitals, 26,516–27,128 samples)
• NDC 17478-0201-15 — PHENYLEPHRINE 2.5 % EYE DROPSAI (217 hospitals, 26,239–27,121 samples)
• NDC 00904-6283-61 — Olanzapine 2.5 mg tabletAI (323 hospitals, 26,542–27,118 samples)
• NDC 65219-0534-10 — Tranexamic acid IV infusion in saline bagAI (90 hospitals, 26,315–27,116 samples)
• NDC 25021-0830-82 — Zoledronic acid 5 mg/100 mL IV infusionAI (736 hospitals, 25,775–27,107 samples)
• NDC 50111-0398-01 — Hydralazine 10 mg oral tabletsAI (427 hospitals, 26,530–27,106 samples)
• NDC 00023-9163-30 — Cyclosporine 0.05% eye drops, single-use dropperAI (560 hospitals, 26,164–27,100 samples)
• NDC 51672-1284-01 — Triamcinolone 0.1% topical ointmentAI (295 hospitals, 26,173–27,100 samples)
• NDC 60505-0593-04 — Travoprost 0.004% eye drops, 2.5 mL bottleAI (206 hospitals, 26,154–27,099 samples)
• NDC 00904-7214-61 — Extended-release bupropion 150 mg tabletAI (313 hospitals, 26,540–27,098 samples)
• NDC 00990-7930-02 — Dextrose 10% intravenous solutionAI (279 hospitals, 26,590–27,094 samples)
• NDC 62756-0427-90 — Ciprofloxacin and dexamethasone ear dropsAI (396 hospitals, 25,922–27,092 samples)
• NDC 00406-0123-01 — Hydrocodone-acetaminophen 5/325 mg tabletAI (356 hospitals, 25,957–27,082 samples)
• NDC 00054-0709-20 — Methadone hydrochloride 5 mg oral tabletsAI (299 hospitals, 26,538–27,078 samples)
• NDC 54838-0506-15 — Hyoscyamine oral liquid 0.125 mg/mLAI (526 hospitals, 26,129–27,065 samples)
• NDC 69097-0720-44 — diclofenac 1 % topical gelAI (261 hospitals, 26,100–27,063 samples)
• NDC 63323-0185-10 — Sterile water for injectionAI (497 hospitals, 26,734–27,049 samples)
• NDC 58602-0006-40 — OLOPATADINE 0.1 % EYE DROPSAI (178 hospitals, 26,149–27,049 samples)
• NDC 71288-0414-03 — Glycopyrrolate injection 0.2 mg/mLAI (215 hospitals, 26,115–27,042 samples)
• NDC 68682-0813-05 — Timolol eye drops 0.5%AI (183 hospitals, 26,148–27,039 samples)
• NDC 43598-0975-58 — Dexmedetomidine IV infusion in salineAI (187 hospitals, 26,148–27,039 samples)
• NDC 00409-7083-10 — CISATRACURIUM 2 MG/ML INTRAVENOUS SOLUTIONAI (48 hospitals, 26,148–27,039 samples)